There are 3164 resources available
LBA74 - Final analysis of the phase III LITESPARK-005 study of belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC)
Presenter: Brian Rini
Session: Proffered paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
441O - A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG)
Presenter: Bart Neyns
Session: Proffered paper session: CNS tumours
Resources:
Abstract
Slides
Webcast
800MO - First report of BCL-2 inhibitor TQB3909 in pts with relapsed or refractory non-Hodgkin lymphoma (NHL) and acute myeloid leukemia (AML): Data from a phase I study
Presenter: Junyuan Qi
Session: Mini oral session 1: Haematological malignancies
Resources:
Abstract
Slides
Webcast
HER2 positive breast cancer
Presenter: Barbara Pistilli
Session: New treatment algorithm in the treatment of metastatic breast cancer in 2024
Resources:
Slides
Webcast
Will theranostics become standard of care?
Presenter: Silke Gillessen
Session: Therapeutic options beyond AR pathway inhibitors: What do we choose next?
Resources:
Slides
Webcast
Basic science rationale
Presenter: Sapna Patel
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
How to handle bias in study design and reporting for ESMO-MCBS grading
Presenter: Nathan Cherny
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
Non-G12C mutations: Future perspectives
Presenter: Colin Lindsay
Session: Treating KRAS-mutated NSCLC
Resources:
Slides
Webcast
Optimal sequencing of therapeutic strategies in immunogenic CRC
Presenter: Thierry André
Session: Metastatic colorectal cancer: Changing paradigms and the relevance for patient care
Resources:
Slides
Webcast
Endogenous retroelements in cancer immunity
Presenter: George Kassiotis
Session: Beyond coding neoantigens: What else is there for T cells to see?
Resources:
Webcast